Obesity Medicine: Diagnosis, Assessment, and Classification
Core concepts
Obesity is a chronic, relapsing, multifactorial disease, not a lifestyle choice. Anchor your studying on the diagnostic framework: body mass index (BMI) as a screening tool (kg/m²), with class categories-overweight 25.0–29.9, class I 30.0–34.9, class II 35.0–39.9, class III ≥40. Know that BMI is a screen, not a diagnosis, and must be paired with clinical assessment.
Understand the additional measures: waist circumference (visceral adiposity risk; elevated at >102 cm in men and >88 cm in women, with lower thresholds in some ancestry groups), waist-to-height ratio, and body composition. Know the obesity-related complications that drive staging: type 2 diabetes, dyslipidemia, hypertension, MASLD, obstructive sleep apnea, osteoarthritis, GERD, PCOS, and mental health conditions. The Edmonton Obesity Staging System (0–4) grades health impact rather than BMI alone-a favorite exam distinction.
Traps
- Equating a BMI category with a treatment decision; therapy is driven by BMI plus comorbidities.
- Forgetting that BMI misclassifies highly muscular individuals and underestimates risk in some Asian populations (lower cutoffs often used).
- Confusing staging systems with classification systems.
- Missing secondary causes (hypothyroidism, Cushing syndrome, hypothalamic disease) and medications that promote weight gain (antipsychotics, some antidepressants, insulin, sulfonylureas, glucocorticoids, some antiepileptics).
Rule of thumb
Use the "screen–assess–stage" sequence: BMI screens, waist and comorbidity assessment characterize, and a staging system quantifies severity to guide intensity of intervention. A 500–750 kcal/day deficit is a common starting estimate for weight loss (~0.5–1 kg/week).
Worked example
A 45-year-old with BMI 33, type 2 diabetes, and OSA: BMI alone says class I, but the presence of two complications justifies intensive, guideline-concordant therapy-not merely "lose weight."